Insider Transactions in Q4 2021 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
31,800
-17.54%
|
$922,200
$29.39 P/Share
|
|
Nov 05
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.82%
|
$260,000
$26.23 P/Share
|
|
Nov 05
2021
|
Steve Aselage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.5%
|
$160,000
$16.23 P/Share
|
|
Nov 02
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Indirect |
3,500
-15.22%
|
$105,000
$30.0 P/Share
|
|
Nov 01
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Indirect |
5,000
-17.86%
|
$145,000
$29.48 P/Share
|
|
Oct 07
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
60,000
-12.82%
|
$1,560,000
$26.25 P/Share
|
|
Oct 07
2021
|
Steve Aselage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+19.37%
|
$960,000
$16.23 P/Share
|
|
Oct 04
2021
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,058
-4.81%
|
$73,392
$24.77 P/Share
|